Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Bronchial Thermoplasty | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Brexucabtagene Autoleucel (e.g., Tecartus) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Brentuximab (e.g., Adcetris) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Brachytherapy, Prostate, Low-dose Rate | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Brachytherapy, Prostate, High-Dose Rate Temporary | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Brachytherapy, Endobronchial | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Chemodenervation, Botulinum Toxins | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Bortezomib (e.g., Velcade) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Bone Morphogenetic Protein | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Bone Mineral Density Study | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Bone Markers (Collagen Crosslinks as Biological Markers of Bone Turnover) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Bone Growth Stimulation, Electrical, Axial Skeleton and SI Joint Fusion | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Bone Growth Stimulation, Electrical, Appendicular Skeleton | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Blood/Platelet-Derived Growth Factors for Wound Healing | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Blinatumomab (e.g., Blincyto) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Blepharoplasty/Blepharoptosis | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Biventricular Pacemakers (Cardiac Resynchronization Therapy) for the Treatment of Congestive Heart Failure | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Biomarkers for Liver Disease | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Biomarker, Serum Human Epididymis Protein 4 (HE4) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Biomarker Testing in Risk Assessment and Management of Cardiovascular Disease | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment and Immunotherapy in Breast Cancer | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Genetic Test: Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment and Immunotherapy in Ovarian Cancer | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Biomarker Testing for Alzheimer's Disease | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Genetic Test: Somatic Biomarker testing (including Liquid Biopsy) for Targeted Treatment and Immunotherapy in Non-Small-Cell Lung Cancer (EGFR, ALK, BRAF, ROS1, RET, MET, KRAS, HER2, PD-L1, TMB) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Biomarker Test, PreDx, Diabetes Risk Score | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Genetic Test: Somatic Biomarker Testing (including Liquid Biopsy) for Targeted Treatment in Metastatic Colorectal Cancer (KRAS, NRAS, BRAF, RET, and HER2) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Genetic Test: Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment and Immunotherapy in Prostate Cancer | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Biomarker Panel Testing for Systemic Lupus Erythematosus | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Biomarker, Auto-antibody, and Molecular Signature Testing for Monitoring Disease Activity in Rheumatoid Arthritis | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Bioimpedance Devices for Detection of Lymphedema | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Biofeedback as a Treatment of Urinary Incontinence in Adults | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Biofeedback as a Treatment of Headache | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Biofeedback as a Treatment of Fecal Incontinence or Constipation | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Biofeedback as a Treatment of Chronic Pain | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Biofeedback | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Bimatoprost (e.g., Durysta) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Bezlotoxumab (e.g., Zinplava) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Bevacizumab (e.g., Avastin) and Biosimilars for Ophthalmic Use | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Bevacizumab (e.g., Avastin) and Biosimilars for Oncologic Indications | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Bevacizumab (e.g., Avastin) and Biosimilars for Non-Oncologic and Non-Ophthalmologic Indications | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Betibeglogene autotemcel (e.g., Zynteglo) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Belimumab (e.g., Benlysta) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Belantamab mafodotin-blmf (e.g., Blenrep) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Bariatric Surgery for ASE/PSE Contracts | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Bariatric Surgery | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Balloon Spacers for Treatment of Irreparable Rotator Cuffs of the Shoulder | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Balloon Ostial Dilation (Balloon Sinuplasty) | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Balloon Dilation of the Eustachian Tube | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Axillary Reverse Mapping for Prevention of Breast Cancer-Related Lymphedema | New policy |
| Aug 2, 2026 | Arkansas Blue Cross and Blue Shield | Axicabtagene Ciloleucel (e.g., Yescarta) | New policy |